Press-release for stocks for viatris inc. for amgn

| Email alert Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
AZN | $68.27 -0.67% -0.67% 3.8M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
GSK | $39.95 -1.36% 0.0% 2.4M

| Email alert Add to watchlist
AZNCF | $135.94 -4.19% 770

| Email alert Add to watchlist
JAZZ | $108.92 -1.79% -1.83% 540K

| Email alert Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M

| Email alert Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M

| Email alert Add to watchlist
cancer cell global growth market

Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ | $0.0018 -50.0% 420K

| 157.14% | O: -14.29% H: 16.67% C: 0.0%
GLAXF | $20.2 -14.18% 510

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
SNYNF | $92.966 -2.18% 630

| -0.76% | O: -1.64% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -3.58% | O: -0.34% H: 0.0% C: -1.2%
NVS | $93.2 -1.28% 0.0% 1.6M

| -8.75% | O: -1.57% H: 0.26% C: -0.47%
GSK | $39.95 -1.36% 0.0% 2.4M

| -3.62% | O: -0.48% H: 0.16% C: 0.0%
BAX | $39.57 -1.17% 0.0% 2.7M

| 1.68% | O: -0.96% H: 5.91% C: 3.74%
ABT | $109.21 0.29% 0.34% 7.3M

| -4.88% | O: -1.41% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M

| -0.59% | O: -2.25% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M

| -10.26% | O: 0.38% H: 0.34% C: -0.72%
america growth market

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $135.94 -4.19% 770

| 3.57% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -4.15% | O: -0.08% H: 3.47% C: -0.25%
NVS | $93.2 -1.28% 0.0% 1.6M

| -12.38% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.95 -1.36% 0.0% 2.4M

| 3.61% | O: 4.04% H: 1.57% C: -3.02%
ABBV | $162.54 0.54% 0.0% 4.8M

| -1.97% | O: 0.5% H: 0.07% C: -0.81%
SNY | $45.81 -0.93% -0.94% 1.4M

| -6.76% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $5.1 -4.67% -4.9% 290K

| 12.28% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.27 -0.67% -0.67% 3.8M

| 2.28% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $265.64 0.05% 0.05% 2M

| -15.61% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published: 2024-01-22 (Crawled : 05:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630

| -8.42% | O: 1.71% H: 0.0% C: -0.15%
AZNCF | $135.94 -4.19% 770

| 3.14% | O: 2.63% H: 0.8% C: 0.75%
NVSEF | $93.6375 6.88% 82K

| -12.49% | O: 1.4% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -0.7% | O: -0.18% H: 2.37% C: 2.28%
NVS | $93.2 -1.28% 0.0% 1.6M

| -12.77% | O: 0.12% H: 0.39% C: 0.1%
ABBV | $162.54 0.54% 0.0% 4.8M

| -0.95% | O: 0.57% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M

| -8.53% | O: -0.21% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M

| 3.29% | O: 1.8% H: 0.14% C: -0.89%
AMGN | $265.64 0.05% 0.05% 2M

| -13.74% | O: 0.29% H: 1.12% C: 0.47%
research growth market

Biosimilars market size to increase by USD 42.22 billion | Market driven by the notable price advantage of biosimilars compared to biologics - Technavio
Published: 2023-10-25 (Crawled : 03:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630

| -10.18% | O: 0.4% H: 1.29% C: 1.29%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 24.26% | O: -0.44% H: 0.33% C: -1.1%
NVS | $93.2 -1.28% 0.0% 1.6M

| -0.53% | O: 0.64% H: 0.46% C: -0.09%
ABBV | $162.54 0.54% 0.0% 4.8M

| 11.37% | O: 0.65% H: 0.54% C: -0.58%
SNY | $45.81 -0.93% -0.94% 1.4M

| -10.54% | O: 1.43% H: 0.64% C: -0.09%
BIIB | $195.16 -0.83% -0.85% 870K

| -21.94% | O: -0.88% H: 0.34% C: -1.27%
AMGN | $265.64 0.05% 0.05% 2M

| -3.84% | O: -0.37% H: 0.58% C: -1.07%
advantage market

Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published: 2023-10-13 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K

| -28.98% | O: -1.86% H: 0.0% C: 0.0%
ALPMY | $9.2715 -1.11% 500K

| -31.27% | O: -2.78% H: 0.04% C: -0.57%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 19.66% | O: -0.21% H: 0.42% C: -1.17%
NVS | $93.2 -1.28% 0.0% 1.6M

| -3.54% | O: -0.55% H: 0.69% C: -0.09%
JNJ | $144.45 -2.13% 0.03% 13M

| -5.23% | O: 0.64% H: 0.0% C: 0.0%
LLY | $746.74 -0.54% 1.01% 2.5M

| 23.38% | O: 1.15% H: 0.0% C: 0.0%
ABBV | $162.54 0.54% 0.0% 4.8M

| 9.02% | O: 0.38% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M

| 0.91% | O: -0.59% H: 0.62% C: -0.56%
AMGN | $265.64 0.05% 0.05% 2M

| -6.85% | O: 0.93% H: 0.26% C: -1.25%
management growing

The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published: 2023-09-25 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 8.89% | O: -0.81% H: 1.63% C: -1.03%
NVSEF | $93.6375 6.88% 82K

| 12.99% | O: 3.72% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 17.43% | O: -0.21% H: 1.14% C: 1.04%
NVS | $93.2 -1.28% 0.0% 1.6M

| -6.65% | O: -0.31% H: 0.98% C: 0.97%
GSK | $39.95 -1.36% 0.0% 2.4M

| 8.2% | O: -0.13% H: 0.91% C: 0.88%
ABBV | $162.54 0.54% 0.0% 4.8M

| 5.66% | O: -0.24% H: 0.0% C: 0.0%
ABT | $109.21 0.29% 0.34% 7.3M

| 10.12% | O: -1.17% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M

| -0.82% | O: -0.06% H: 0.1% C: -0.25%
abbvie treatment thyroid market

Advancements in Atherosclerosis Treatments Fuel Expansion of the Global Market to 2032
Published: 2023-09-07 (Crawled : 00:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M

| 13.2% | O: 0.0% H: 2.1% C: 1.1%
NVS | $93.2 -1.28% 0.0% 1.6M

| -4.49% | O: -0.29% H: 0.38% C: -0.22%
JNJ | $144.45 -2.13% 0.03% 13M

| -7.78% | O: -0.34% H: 0.0% C: 0.0%
BHC | $8.74 1.28% 0.11% 2.5M

| 2.49% | O: 0.0% H: 3.09% C: 2.61%
SNY | $45.81 -0.93% -0.94% 1.4M

| -11.94% | O: 0.46% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M

| 4.37% | O: 0.53% H: 1.79% C: 1.44%
expansion global market

Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
MREO | $2.68 0.38% 0.37% 570K

| Email alert Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M

| Email alert Add to watchlist
KIDS | $30.26 -0.62% -0.63% 230K

| Email alert Add to watchlist
LLY | $746.74 -0.54% 1.01% 2.5M

| Email alert Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
RARE | $42.32 -1.28% -1.3% 890K

| Email alert Add to watchlist
treatment research global collaboration growth

Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M

| 1.43% | O: -0.99% H: 1.45% C: 1.36%
ABBV | $162.54 0.54% 0.0% 4.8M

| 6.62% | O: 0.56% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M

| 1.7% | O: 2.02% H: 0.72% C: -0.49%
treatment global market

Tyrosine Kinase Inhibitors Market size to grow by USD 24.12 billion from 2022 to 2027 | High target affinity and specificity of tyrosine kinase inhibitors boost the market growth - Technavio
Published: 2023-07-26 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 12.04% | O: 2.38% H: 2.49% C: 2.49%
AZNCF | $135.94 -4.19% 770

| -3.25% | O: -0.04% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 8.02% | O: -0.24% H: 0.48% C: -1.2%
NVS | $93.2 -1.28% 0.0% 1.6M

| -9.13% | O: 0.7% H: 0.12% C: -0.76%
GSK | $39.95 -1.36% 0.0% 2.4M

| 12.91% | O: 1.03% H: 0.39% C: -1.02%
ABBV | $162.54 0.54% 0.0% 4.8M

| 14.29% | O: 2.13% H: 4.77% C: 3.02%
PBYI | $5.1 -4.67% -4.9% 290K

| 52.42% | O: 0.28% H: 0.85% C: -1.99%
AZN | $68.27 -0.67% -0.67% 3.8M

| 0.42% | O: 0.42% H: 0.55% C: -0.86%
AMGN | $265.64 0.05% 0.05% 2M

| 12.88% | O: -0.31% H: 1.71% C: 0.67%
growth market

United States Biosimilar Market Report 2023: Sector is Expected to Reach $50.68 Billion in 2027 at a CAGR of 40.17%
Published: 2023-06-30 (Crawled : 19:00) - prnewswire.com
VTRS | $11.12 -1.77% -1.8% 6.8M

| Email alert Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M

| Email alert Add to watchlist
biosimilar report expected reach market

Autoinjectors Market worth $1.7 billion | MarketsandMarkets
Published: 2023-06-02 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| 15.61% | O: 0.99% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 23.31% | O: 0.76% H: 1.08% C: 0.86%
WST | $379.48 0.18% 0.0% 490K

| 10.92% | O: 0.34% H: 0.36% C: 0.3%
NVS | $93.2 -1.28% 0.0% 1.6M

| -2.78% | O: 1.03% H: 0.84% C: 0.82%
LLY | $746.74 -0.54% 1.01% 2.5M

| 72.0% | O: 0.79% H: 1.08% C: 0.54%
BDX | $231.01 -1.58% 0.0% 1.1M

| -5.4% | O: 0.56% H: 1.61% C: 0.92%
ABBV | $162.54 0.54% 0.0% 4.8M

| 21.16% | O: 0.2% H: 2.44% C: 2.36%
AMGN | $265.64 0.05% 0.05% 2M

| 23.91% | O: -0.24% H: 2.34% C: 2.02%
market

Autoinjectors market size to grow by USD 134,014.58 million from 2022 to 2027, Driven by increasing prevalence of allergies and need for immediate care - Technavio
Published: 2023-04-18 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 9.4% | O: 0.19% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 14.57% | O: -0.71% H: 1.27% C: 0.2%
GSK | $39.95 -1.36% 0.0% 2.4M

| 10.11% | O: 0.6% H: 0.14% C: -0.19%
ABBV | $162.54 0.54% 0.0% 4.8M

| 1.3% | O: -0.58% H: 1.75% C: 1.6%
AMGN | $265.64 0.05% 0.05% 2M

| 7.89% | O: -0.34% H: 0.62% C: 0.39%
care market

Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published: 2023-04-13 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 8.89% | O: 0.54% H: 0.0% C: 0.0%
SNYNF | $92.966 -2.18% 630

| -17.91% | O: -1.1% H: 0.0% C: 0.0%
AZNCF | $135.94 -4.19% 770

| -7.68% | O: 0.0% H: 1.63% C: 1.63%
NVSEF | $93.6375 6.88% 82K

| 16.68% | O: 1.25% H: 0.51% C: 0.51%
VTRS | $11.12 -1.77% -1.8% 6.8M

| 15.27% | O: 0.31% H: 1.42% C: 0.71%
NVS | $93.2 -1.28% 0.0% 1.6M

| -2.14% | O: 1.3% H: 0.56% C: 0.51%
GSK | $39.95 -1.36% 0.0% 2.4M

| 7.4% | O: 0.85% H: 0.76% C: 0.76%
ABBV | $162.54 0.54% 0.0% 4.8M

| -0.42% | O: -0.84% H: 1.16% C: 1.05%
SNY | $45.81 -0.93% -0.94% 1.4M

| -16.18% | O: 0.29% H: 0.0% C: 0.0%
PBYI | $5.1 -4.67% -4.9% 290K

| 83.85% | O: -0.34% H: 10.17% C: 6.9%
AZN | $68.27 -0.67% -0.67% 3.8M

| -6.82% | O: 0.39% H: 1.05% C: 0.97%
AMGN | $265.64 0.05% 0.05% 2M

| 6.42% | O: -0.36% H: 1.33% C: 1.14%
abbvie breast cancer therapeutics market

Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | $265.64 0.05% 0.05% 2M

| Email alert Add to watchlist
CSLLY | $89.5 3.3% 44K

| Email alert Add to watchlist
MNK | News | $0.3402 -0.06% 540K

| Email alert Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510

| Email alert Add to watchlist
MNKPF | News | $17.25

| Email alert Add to watchlist
ABBV | $162.54 0.54% 0.0% 4.8M

| Email alert Add to watchlist
ENDP | $0.2926 -9.6%

| Email alert Add to watchlist
ALPMY | $9.2715 -1.11% 500K

| Email alert Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K

| Email alert Add to watchlist
UCBJY | $63.0 -4.38% 11K

| Email alert Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M

| Email alert Add to watchlist
ALPMF | $9.48 43.47% 1.7K

| Email alert Add to watchlist
SNYNF | $92.966 -2.18% 630

| Email alert Add to watchlist
BHC | $8.74 1.28% 0.11% 2.5M

| Email alert Add to watchlist
UCBJF | $126.05 -39.66% 100

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
ENDPQ | $0.0018 -50.0% 420K

| Email alert Add to watchlist
CMXHF | $180.75 -19.21% 33

| Email alert Add to watchlist
JNJ | $144.45 -2.13% 0.03% 13M

| Email alert Add to watchlist
MNKKQ | News | $0.02

| Email alert Add to watchlist
GSK | $39.95 -1.36% 0.0% 2.4M

| Email alert Add to watchlist
NVO | $123.45 -0.36% 0.03% 3M

| Email alert Add to watchlist
global report

Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

| 23.48% | O: -1.1% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -2.75% | O: -0.69% H: 0.87% C: 0.69%
NVS | $93.2 -1.28% 0.0% 1.6M

| 1.72% | O: -1.97% H: 0.11% C: -1.25%
LLY | $746.74 -0.54% 1.01% 2.5M

| 114.67% | O: 0.36% H: 0.34% C: -0.85%
BHC | $8.74 1.28% 0.11% 2.5M

| 2.98% | O: 1.91% H: 3.28% C: -0.23%
ABBV | $162.54 0.54% 0.0% 4.8M

| 9.39% | O: 0.09% H: 0.53% C: -0.35%
AMGN | $265.64 0.05% 0.05% 2M

| 3.5% | O: 0.0% H: 0.06% C: -0.65%
leo pharma global report therapeutics psoriasis market

Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 13.48% | O: 1.12% H: 0.0% C: -1.68%
SNYNF | $92.966 -2.18% 630

| -6.82% | O: -2.5% H: 0.0% C: 0.0%
AZNCF | $135.94 -4.19% 770

| -5.35% | O: -1.16% H: 1.62% C: -0.54%
NVSEF | $93.6375 6.88% 82K

| 22.87% | O: 0.05% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -4.39% | O: -0.17% H: 0.25% C: -2.96%
TMO | $554.55 -0.6% 0.0% 1M

| -5.1% | O: 0.56% H: 0.97% C: -1.87%
NVO | $123.45 -0.36% 0.03% 3M

| -10.85% | O: 0.57% H: 0.84% C: -0.01%
NVS | $93.2 -1.28% 0.0% 1.6M

| 2.2% | O: 0.93% H: 0.01% C: -1.16%
JNJ | $144.45 -2.13% 0.03% 13M

| -14.37% | O: -0.41% H: 0.2% C: -1.1%
GSK | $39.95 -1.36% 0.0% 2.4M

| 13.89% | O: -0.03% H: 0.17% C: -1.01%
LLY | $746.74 -0.54% 1.01% 2.5M

| 109.86% | O: -0.4% H: 0.75% C: -1.21%
ABT | $109.21 0.29% 0.34% 7.3M

| -3.97% | O: -0.16% H: 0.33% C: -1.5%
SNY | $45.81 -0.93% -0.94% 1.4M

| -5.94% | O: -0.14% H: 0.0% C: 0.0%
BIIB | $195.16 -0.83% -0.85% 870K

| -32.04% | O: 0.34% H: 0.46% C: -2.45%
AZN | $68.27 -0.67% -0.67% 3.8M

| -2.84% | O: 1.36% H: 0.33% C: -1.13%
AMGN | $265.64 0.05% 0.05% 2M

| -1.45% | O: 0.0% H: 0.41% C: -1.87%
therapy growth

Generic drugs market size to increase by USD 176.25 billion; North America to contribute 37% of market growth - Technavio
Published: 2023-01-11 (Crawled : 00:00) - prnewswire.com
ENDPQ | $0.0018 -50.0% 420K

| -98.03% | O: -3.17% H: 7.0% C: 1.69%
TEVJF | $12.37 -24.22% 380

| 19.06% | O: 5.87% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 15.17% | O: -0.51% H: 0.0% C: 0.0%
SNYNF | $92.966 -2.18% 630

| -4.54% | O: 0.37% H: 1.64% C: 1.64%
NVSEF | $93.6375 6.88% 82K

| 24.23% | O: 0.37% H: 0.0% C: -0.49%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -3.82% | O: -0.08% H: 0.6% C: -0.85%
NVS | $93.2 -1.28% 0.0% 1.6M

| 4.36% | O: -0.46% H: 0.91% C: 0.57%
GSK | $39.95 -1.36% 0.0% 2.4M

| 16.82% | O: 0.2% H: 1.55% C: 1.18%
BAX | $39.57 -1.17% 0.0% 2.7M

| -11.88% | O: -0.11% H: 0.55% C: -0.66%
ABT | $109.21 0.29% 0.34% 7.3M

| -3.76% | O: -1.03% H: 0.35% C: -0.56%
SNY | $45.81 -0.93% -0.94% 1.4M

| -3.46% | O: -0.38% H: 0.0% C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M

| -2.71% | O: -0.36% H: 0.27% C: -0.37%
america growth market

G-CSFPEG-G-CSF Market Set to Reach at USD 5,685.40 Million by 2030, Size, Share, Demand, Future Growth and Competitors Outlook
Published: 2023-01-11 (Crawled : 23:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380

| 19.06% | O: 5.87% H: 0.0% C: 0.0%
VTRS | $11.12 -1.77% -1.8% 6.8M

| -3.82% | O: -0.08% H: 0.6% C: -0.85%
SPPI | $1.03 -0.97% 0

| 101.96% | O: -1.96% H: 8.0% C: 5.48%
AMGN | $265.64 0.05% 0.05% 2M

| -2.71% | O: -0.36% H: 0.27% C: -0.37%
set growth market

← Previous
1
2
Next →

Gainers vs Losers

58%

42%

Top 10 Gainers

WISA 4 | $6.06 246.29% 71.12% 200M

Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K

Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M

SXTC | $1.68 43.59% 30.36% 34M

DYNT | $0.531 43.36% 30.24% 22M

KA | $0.4796 41.06% 29.11% 5.3M

PALI | $5.86 40.87% 29.01% 29M

CLNN | $0.319 -3.74% 28.75% 6.3M

BSGM | $1.52 38.18% 27.63% 3.3M